Vitamins K1 And K2 Are Associated With Cardiovascular Disease-Related Hospitalization Risk
10 replies
-
Good news is that Vitamin K1 and K2 reduce CVD when taken in the right doses.
-
1200mcg mk7 every day, not suppose to microdose k2
-
Life Extension-
Super K:
Vitamin K1 (as phytonadione)
1500 mcg
Vitamin K2 (as menaquinone-4)
1000 mcg
Vitamin K2 (as trans menaquinone-7)
100 mcg
Super K Elite:
Vitamin K1 (as phytonadione)
2000 mcg
Vitamin K2 (as menaquinone-4)
1500 mcg
Vitamin K2 (as menaquinone-6) 11 mcg Vitamin K2 (as trans menaquinone-7) 181 mcg Vitamin K2 (as menaquinone-9)
43 mcg
Wouldn't much of the effects of K depend on activity and plasma levels of Vit D?
-
I got stents in 2015 at which time I was also diagnosed with Mitral Valve Regurgitation, caused by calcification of the mitral valve.
Since that time I have been taking a product called “Koncentrated-K” - one capsule daily. This product has high dosages if K1, MK4 and MK7.
Last year (2020) my cardiologist did an echocardiogram and said there was no sign of any mitral valve issues! -
A question about this study is whether there is a negative effect of the other contents of cheese and other dairy products that undermines the benefits of menaquinones. I tend to take MK4, 7 and 9 as supplements.